In this insightful interview, Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd, discusses the company's recent impressive financial performance, strategies for sustained growth, and the evolving landscape of the Indian pharmaceutical industry.

From Rs 21.37 (52-week low) to Rs 45.84 per share, the stock gave multibagger returns of 114.5 per cent and a whopping 640 per cent in 5 years.

The Board of Directors approved a 2:1 bonus issue (i.e., 2 shares for every 1 share held), subject to members' approval. Here’s the record date.

The electrical automation and information technology solution provider for the marine and industrial sectors secures back-to-back orders worth Rs 16.2 crore this week.

Stock hit the upper circuit after the company announced it had inked a memorandum of understanding (MoU) with Astra Microwave Products to collaborate on developing and marketing products.

Today, shares of the company plunged 3.36 per cent to Rs 3.45 per share from its previous closing of Rs 3.57 with an intraday high of Rs 3.63 and an intraday low of Rs 3.42.

The company has a market cap of Rs 54.32 crore and mixed sets of numbers in its quarterly results (Q1FY25) and annual results (FY24).